EP12.01. Validation of the ALK-Brain Prognostic Index (ALK-BPI) Model in Patients with ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Georgios Tsakonas
Meta Tag
Speaker Georgios Tsakonas
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
ALK-Brain Prognostic Index
ALK-rearranged non-small cell lung cancer
brain metastases
ALK inhibitors
performance status
overall survival
prognostic model
clinical utility
treatment decisions
Powered By